{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:09:28Z","timestamp":1793351368986,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018711","name":"The 2nd Affiliated Hospital of Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005952","name":"Ministry of Human Resources and Social Security of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005952","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.biomaterials.2026.124405","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:48:16Z","timestamp":1782542896000},"page":"124405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization"],"prefix":"10.1016","volume":"335","author":[{"given":"Peng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiong-Cheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Hui","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Yuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Chao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3399-1289","authenticated-orcid":false,"given":"Ben Zhong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-8663","authenticated-orcid":false,"given":"Da-Yong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124405_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.biomaterials.2026.124405_bib2","article-title":"New treatment options for non-muscle-invasive bladder cancer","volume":"45","author":"Filon","year":"2025","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10.1016\/j.biomaterials.2026.124405_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in Situ)-A summary of the 2024 Guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur. Urol."},{"key":"10.1016\/j.biomaterials.2026.124405_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.603","article-title":"DNA nanomachine-driven chemodynamic therapy against glioblastoma","volume":"5","author":"Li","year":"2024","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202116893","article-title":"In situ constructed nano-drug depots through intracellular hydrolytic condensation for chemotherapy of bladder cancer","volume":"61","author":"Hou","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124405_bib6","article-title":"In situ liquid-liquid phase separation of peptides into droplets targeting membraneless organelles for enhanced cancer chemotherapy","volume":"37","author":"Wang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib7","doi-asserted-by":"crossref","first-page":"31310","DOI":"10.1021\/jacs.5c10714","article-title":"A sterically controlled and tumor-activated programmable singlet-oxygen battery","volume":"147","author":"Tian","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124405_bib8","doi-asserted-by":"crossref","first-page":"16458","DOI":"10.1021\/jacs.4c02500","article-title":"Programmable singlet oxygen battery for automated photodynamic therapy enabled by pyridone-pyridine tautomer engineering","volume":"146","author":"Tian","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124405_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acsptsci.3c00269","article-title":"Peptide-Drug conjugates: design, chemistry, and drug delivery system as a novel cancer theranostic","volume":"7","author":"Rizvi","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.biomaterials.2026.124405_bib10","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1021\/acs.jmedchem.3c01835","article-title":"Peptide-drug conjugates: an emerging direction for the next generation of peptide therapeutics","volume":"67","author":"Dean","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124405_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41392-024-01856-7","article-title":"Exploring treatment options in cancer: tumor treatment strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124405_bib12","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1158\/1535-7163.MCT-21-0875","article-title":"BT8009; A Nectin-4 targeting bicycle toxin conjugate for treatment of solid tumors","volume":"21","author":"Rigby","year":"2022","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124405_bib13","doi-asserted-by":"crossref","first-page":"14337","DOI":"10.1021\/acs.jmedchem.2c00065","article-title":"Discovery of BT8009: a Nectin-4 targeting bicycle toxin conjugate for the treatment of cancer","volume":"65","author":"Mudd","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2026.124405_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12951-025-03277-2","article-title":"Current progress and remaining challenges of peptide-drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?","volume":"23","author":"Wang","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biomaterials.2026.124405_bib15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.scib.2024.10.032","article-title":"In vivo self-assembled bispecific fluorescence probe for early detection of bladder cancer and metastasis","volume":"70","author":"Hou","year":"2025","journal-title":"Sci. Bull."},{"key":"10.1016\/j.biomaterials.2026.124405_bib16","doi-asserted-by":"crossref","first-page":"nwae028","DOI":"10.1093\/nsr\/nwae028","article-title":"Inducing mitochondriopathy-like damages by transformable nucleopeptide nanoparticles for targeted therapy of bladder cancer","volume":"11","author":"Hou","year":"2024","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.biomaterials.2026.124405_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2026.118706","article-title":"Progress and trends in PET\/NIRF-based dual-modality imaging probes","volume":"197","author":"Li","year":"2026","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.biomaterials.2026.124405_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303831","article-title":"An in vivo self-assembled bispecific nanoblocker for enhancing tumor immunotherapy","volume":"35","author":"Hu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121523","article-title":"OGA activated glycopeptide-based nano-activator to activate PKM2 tetramerization for switching catabolic pathways and sensitizing chemotherapy resistance","volume":"284","author":"Hou","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124405_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123549","article-title":"Translational contrast agents for use in fluorescence image-guided tumor surgery","volume":"325","author":"Hou","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124405_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.70119","article-title":"GED-CRN breaks the data barrier: High-Fidelity electron density prediction using only 19 training molecules","volume":"6","author":"Gong","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.70024","article-title":"Harnessing photocycloreversion for dimer construction and photoactivation: from molecule to aggregate","volume":"6","author":"Ding","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202307288","article-title":"Activatable type I photosensitizer with quenched photosensitization pre and post photodynamic therapy","volume":"62","author":"Tian","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124405_bib24","article-title":"Unconventional PROTACs for targeted protein degradation in cancer therapy","volume":"64","author":"Zhang","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2026.124405_bib25","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1021\/acsanm.4c01611","article-title":"Reactive oxygen species-activated self-accelerated drug release nanoparticles for enhanced cancer combination therapy","volume":"7","author":"Jia","year":"2024","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib26","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1039\/D5CS00141B","article-title":"Intracellular aggregation of exogenous molecules for biomedical applications","volume":"54","author":"Hou","year":"2025","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2026.124405_bib27","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1021\/jacs.4c00826","article-title":"Sulfatase-induced in situ formulation of antineoplastic Supra-PROTACs","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124405_bib28","article-title":"A transformable supramolecular bispecific cell engager for augmenting natural killer and T cell-based cancer immunotherapy","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib29","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1039\/D2CS00999D","article-title":"Synthesizing biomaterials in living organisms","volume":"52","author":"Zhang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2026.124405_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.533","article-title":"From small to large\u2014The application of in situ polymerization within tumor cells","volume":"5","author":"Jia","year":"2024","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121139","article-title":"Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency","volume":"278","author":"Wang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124405_bib32","article-title":"Intracellular condensates of oligopeptide for targeting lysosome and addressing multiple drug resistance of cancer","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.672","article-title":"Metal-coordinated amino acid\/peptide\/protein-based supramolecular self-assembled nanomaterials for anticancer applications","volume":"6","author":"Shabbir","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.740","article-title":"A peptide-derived aggregation-induced emission nanobioprobe: unlocking selective detection of Fusobacterium nucleatum and noninvasive screening of colorectal cancer","volume":"6","author":"Liu","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.biomaterials.2026.124405_bib35","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1007\/s00259-022-05849-y","article-title":"CXCR4-targeted theranostics in oncology","volume":"49","author":"Buck","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.biomaterials.2026.124405_bib36","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.2967\/jnumed.111.098798","article-title":"PET of CXCR4 expression by a (68)Ga-labeled highly specific targeted contrast agent","volume":"52","author":"Gourni","year":"2011","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biomaterials.2026.124405_bib37","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41467-023-44665-2","article-title":"In vivo assembly enhanced binding effect augments tumor specific ferroptosis therapy","volume":"15","author":"Hou","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124405_bib38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41565-025-01857-9","article-title":"Tandem-controlled lysosomal assembly of nanofibres induces pyroptosis for cancer immunotherapy","volume":"20","author":"Zhang","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124405_bib39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-023-05786-0","article-title":"Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biomaterials.2026.124405_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biomaterials.2026.124405_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J. Urol."},{"key":"10.1016\/j.biomaterials.2026.124405_bib42","doi-asserted-by":"crossref","first-page":"35507","DOI":"10.1021\/acsnano.4c12967","article-title":"Cascade-activatable Nanoprodrug system augments sonochemotherapy of bladder cancer","volume":"18","author":"Hou","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124405_bib43","article-title":"Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124405_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114829","article-title":"In situ delivery of JPH203 via camptothecin-peptide conjugate nanoassemblies to trigger ferroptosis in triple-negative breast cancer","volume":"393","author":"Zhang","year":"2026","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124405_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.actbio.2023.06.036","article-title":"A biomimetic peptide-drug supramolecular hydrogel as eyedrops enables controlled release of ophthalmic drugs","volume":"167","author":"Pan","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124405_bib46","doi-asserted-by":"crossref","first-page":"9546","DOI":"10.1021\/acsnano.2c02804","article-title":"Energy landscapes of supramolecular peptide-drug conjugates directed by linker selection and drug topology","volume":"16","author":"Sis","year":"2022","journal-title":"ACS Nano"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:22:17Z","timestamp":1785360137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S0142961226004291"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124405","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In-situ cascade assembled peptide-drug conjugate for the treatment of bladder cancer by enhancing membrane-entry and lysosome destabilization","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124405"}}